A Germline Test to Uncover Your Hereditary & Familial Cancer Risk
More than 11 Distinct Hereditary and Familial Cancers
Pre and Post-test Genetic Counselling
NCCN Guidelines Recommend Germline Testing
Comprehensive Report with Actionable Insights
What is OncoRisk?
OncoRisk is a hereditary cancer test that represents a robust solution, examining a comprehensive panel of 74 genes connected to a spectrum of more than 11 distinct hereditary and familial cancers.
Benefits to Individuals Undergoing Germline Testing:
Gain insight into your hereditary cancer risk, to take proactive steps for your health.
Identify potential risks early, enabling timely interventions and personalised care.
Make informed choices about your health, lifestyle, and medical decisions.
Protect your loved ones by understanding the genetic basis of hereditary cancers.
Receive a comprehensive report with actionable information for tailored care planning.
Key actionable genes included:
Features of the OncoRisk
Comprehensive analysis of 74 genes associated with more than 11 hereditary and familial cancers.
Uncovers genetic mutations impacting the occurrence of hereditary cancers.
Comprehensive guide included with every report to effectively utilise results for care planning.
Designed for both oncologists and patients to easily understand and apply.
How can OncoRisk predict the onset of cancer?
Identify at-high-risk unaffected relatives of a cancer patient
Prediction of risk which can lead to early detection
Implement rigorous screening protocols for individuals at high risk and prognosticate the potential for cancer development.
Timely intervention of cancer translates to enhanced treatment outcomes and prolonged periods of disease-free survival.
Informed Surgical Choices, such as Prophylactic Mastectomy and Bilateral Salpingo-Oophorectomy
Genelist for OncoRisk
